Abstract:OBJECTIVE:To investigate the expression of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) and estrogen receptor subtypes in normal, hyperplastic, and carcinomatous endometrium and to explore their possible roles in carcinogenesis and progression of endometrial carcinoma. METHODS:Immunohistochemistry and semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) were applied to detect the protein and mRNA expression of RCAS1, estrogen receptor (ER) alpha and ERbeta in 20 specimens of normal endometrium, 24 specimens of hyperplastic endometrium, and 50 specimens of carcinomatous endometrium. Western blotting was used to detect the RCAS1 protein expression. RESULTS:Normal endometrium and simple and complex hyperplastic endometrium showed a P pattern of RCAS1 expression; carcinomatous endometrium showed the D pattern; and the atypical hyperplastic endometrium showed both, 30% (6/20) of which showed D pattern. The high level RCAS1 protein expression rates of the normal, simple and complex hyperplasia, atypical hyperplasia, and endometrial carcinoma were 0% (0/20), 9.1% (2/22), 45.0% (9/20), and 68.0% (34/50) respectively with a significant difference between any 2 groups (all P < 0.05). The high level expression of RCAS1 was detected more frequently in the carcinomatous endometrium with deep myometrial invasion, vascular invasion, and positive of ERalpha (all P < 0.05). The Western blotting and RT-PCR results were correlated with the immunohistochemistry results. The RCAS1 mRNA level was positively correlated with the ERalphamRNA level (P < 0.01), but not correlated with the ERbetamRNA level (P > 0.05). CONCLUSION:The expression and distribution of RCAS1 may be involved in the malignant transformation of endometrium, and RCAS1 coexpression with ERalpha may be associated with the development and metastasis of endometrial carcinoma.

Estrogen and progesterone receptor in cytosols and nuclei of esophageal squamous carcinoma tissues by DCC method

Estrogen Receptor Beta Variants Mrna Expressions in Gastric Cancer Tissues and Association with Clinicopathologic Parameters

Correlation Between Expressions of Estrogen Receptor, Thymidylate Synthase and CAF Regime Sensibility in Breast Carcinoma

Prognostic Role of Estrogen Receptor Α and Estrogen Receptor Β in Gastric Cancer

[Expression of Retinoic Acid Receptor-Beta Mrna and P16, P53, Ki67 Proteins in Esophageal Carcinoma and Its Precursor Lesions].

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

Expression of Aromatase Cytochrome P450 and Estrogen Receptor Β in Cervical Carcinoma Tissues and Its Clinical Significance

Expression of Estrogen and Progesterone Receptor Subtypes in Human Endometrial Carcinoma Tissues

Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction.

Correlation Between Secreted Protein Acidic and Rich in Cysteine Protein Expression and the Prognosis of Postoperative Patients Exhibiting Esophageal Squamous Cell Carcinoma

[Relative Quantification of Cytokeratin 19 Transcription in Oral Squamous Cell Carcinoma Tissues by Fluorescent Quantitive Real-Time RT-PCR].

Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma

The relationship between the expression and clinical significance of Nrf2 and Bcl-2 in esophageal squamous cell carcinoma

Expression Of G Protein-Coupled Estrogen Receptor In Gastric Cancer Tissues

Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues

The expression of lnc-CCDC170-4:1, ESR1, lncRNA SRA, and CYP19A1 in cervical squamous cell carcinoma and their relationship with the clinical characteristics

Study of Serum Level of Sex Hormones and Expression of Their Receptors in Patients with Bronchogenic Carcinoma

[Expression of Receptor-Binding Cancer Antigen Expressed on SiSo Cells in Endometrial Carcinoma and the Correlation Thereof with the Expression of Estrogen Receptor Subtypes].

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma